Literature DB >> 2108081

Pasteurella multocida infections in mice with reference to haemorrhagic septicaemia in cattle and buffalo.

H J Dawkins, R B Johnson, T L Spencer, B Adler.   

Abstract

Haemorrhagic septicaemia (HS) is an infectious disease of cattle and buffalo caused by particular serotypes of Pasteurella multocida and is one of the most economically important livestock diseases in South-East Asia. While HS has been recognized for many years, very little is understood about the disease, primarily because of the expense of cattle and a lack of suitable animal models. The suitability of using mice to study HS was assessed using parameters such as the critical pathogenic dose, kinetics of infection, pathology of disease and resistance to reinfection. Pasteurella multocida M1404, the type strain for Carter group B, the serotype responsible for Asian HS, was injected intraperitoneally into BALB/c mice. As few as 20 colony forming units produced an overwhelming septicaemia in mice in less than 30 h. The kinetics of infection demonstrated a very rapid in vivo multiplication rate. There was no evidence of inhibition of bacterial cell growth by natural host defence mechanisms, even with the very small inocula used. The gross pathology of the disease in mice was characterized by splenomegaly, lymphadenopathy and petechial haemorrhages similar to that observed in cattle and buffalo with HS. Mice were found to develop a short-lived resistance to reinfection following a primary infection which had been successfully treated with antibiotics. The mouse would seem to provide an ideal tool by which to study HS, but warrant further studies in order to be able to critically assess it as a model for this economically important disease.

Entities:  

Mesh:

Year:  1990        PMID: 2108081     DOI: 10.1038/icb.1990.8

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  7 in total

1.  Mouse model of haemorrhagic septicaemia: dissemination and multiplication of Pasteurella multocida B:2 in vital organs after intranasal and subcutaneous challenge in mice.

Authors:  Subhash Kharb; Shiv Charan
Journal:  Vet Res Commun       Date:  2012-12-14       Impact factor: 2.459

2.  Protective immunity conferred by attenuated aroA derivatives of Pasteurella multocida B:2 strains in a mouse model of hemorrhagic septicemia.

Authors:  Mohammad Tabatabaei; Zhiqi Liu; Anna Finucane; Roger Parton; John Coote
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

3.  Genome wide host gene expression analysis in mice experimentally infected with Pasteurella multocida.

Authors:  G Bhuvana Priya; Viswas Konasagara Nagaleekar; A Arun Prince Milton; M Saminathan; Amod Kumar; Amit Ranjan Sahoo; Sajad Ahmad Wani; Amit Kumar; S K Gupta; Aditya P Sahoo; A K Tiwari; R K Agarwal; Ravi Kumar Gandham
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

4.  Efficacy of bacteriophage Lysed Pasteurella marker vaccine in laboratory animal models with a novel DIVA for haemorrhagic septicaemia.

Authors:  Sabia Qureshi; Hari Mohan Saxena
Journal:  Saudi J Biol Sci       Date:  2017-05-05       Impact factor: 4.219

5.  Pasteurellaceae members with similar morphological patterns associated with respiratory manifestations in ducks.

Authors:  Samah Eid; Sherif Marouf; Hefny Y Hefny; Nayera M Al-Atfeehy
Journal:  Vet World       Date:  2019-12-26

6.  Dispositions of enrofloxacin and its major metabolite ciprofloxacin in Thai swamp buffaloes.

Authors:  Nitwarat Ruennarong; Kannika Wongpanit; Chainarong Sakulthaew; Mario Giorgi; Susumu Kumagai; Amnart Poapolathep; Saranya Poapolathep
Journal:  J Vet Med Sci       Date:  2015-11-20       Impact factor: 1.267

Review 7.  Transboundary Animal Diseases, an Overview of 17 Diseases with Potential for Global Spread and Serious Consequences.

Authors:  Elizabeth A Clemmons; Kendra J Alfson; John W Dutton
Journal:  Animals (Basel)       Date:  2021-07-08       Impact factor: 2.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.